BioAge Labs, Inc. (BIOA)
5.57
-0.37
(-6.23%)
USD |
NASDAQ |
Oct 13, 16:00
5.58
+0.01
(+0.18%)
Pre-Market: 08:07
BioAge Labs EPS Diluted (TTM) : -2.387 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.387 |
| March 31, 2026 | -2.406 |
| December 31, 2025 | -2.243 |
| September 30, 2025 | -2.114 |
| June 30, 2025 | -2.236 |
| March 31, 2025 | -2.032 |
| December 31, 2024 | -2.052 |
| Date | Value |
|---|---|
| September 30, 2024 | -2.075 |
| June 30, 2024 | -1.818 |
| March 31, 2024 | -1.924 |
| December 31, 2023 | -1.868 |
| September 30, 2023 | -1.255 |
| June 30, 2023 | -0.8274 |
| March 31, 2023 | -0.3244 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Neumora Therapeutics, Inc. | -1.233 |
| Alumis, Inc. | -3.809 |
| ANI Pharmaceuticals, Inc. | 4.632 |
| Corcept Therapeutics, Inc. | 0.4187 |
| Veru, Inc. | -0.6109 |